Multimodality imaging in vivo for preclinical assessment of tumor-targeted doxorubicin nanoparticles

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Hwang, Jae Youn ^a   Park, Jinhyung ^b   Kang, Bong Jin ^b   Lubow, David J ^a   Chu, David ^a   Farkas, Daniel L ^a,b   Shung, K Kirk ^b   Medina Kauwe, Lali K ^a,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b University of Southern California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOFLUORESCENCE IMAGING; BIOLOGICAL MONITORING; CANCER INHIBITION; CELL LEVEL; CELL NUCLEUS; CONFOCAL IMAGING; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG PENETRATION; DRUG SCREENING; DRUG TARGETING; FEMALE; FLUORESCENCE ANALYSIS; FLUORESCENCE INTENSITY IMAGING; HIGH FREQUENCY ULTRASOUND IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VIVO STUDY; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; SPECTRAL IMAGING; TUMOR; TUMOR CELL; TUMOR GROWTH; VIRUS LIKE AGENT; ANIMAL; CHEMISTRY; DRUG EFFECT; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; SPECTROFLUOROMETRY; TREATMENT OUTCOME; TUMOR CELL LINE; ULTRASOUND;

MUS;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; MICE; MOLECULAR IMAGING; MOLECULAR TARGETED THERAPY; NANOPARTICLES; RECEPTOR, ERBB-2; SPECTROMETRY, FLUORESCENCE; TREATMENT OUTCOME; ULTRASONICS;

EID: 84859237337     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034463     Document Type: Article

References (34)

1. Cherry SR, (2006) Multimodality in vivo imaging systems: twice the power or double the trouble? Annu Rev Biomed Eng 8: 35-62.
2. Zaidi H, Prasad R, (2009) Advances in multimodality molecular imaging. J Med Phys 34: 122-128.
3. Cruz LJ, Tacken PJ, Bonetto F, Buschow SI, Croes HJ, et al. (2011) Multimodal imaging of nanovaccine carriers targeted to human dendritic cells. Mol Pharm 8: 520-531.
4. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, et al. (2005) Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 96: 327-336.
5. Medarova Z, Evgenov NV, Dai G, Bonner-Weir S, Moore A, (2006) In vivo multimodal imaging of transplanted pancreatic islets. Nat Protoc 1: 429-435.
6. Kim J, Piao Y, Hyeon T, (2009) Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 38: 372-390.
7. Waerzeggers Y, Klein M, Miletic H, Himmelreich U, Li H, et al. (2008) Multimodal imaging of neural progenitor cell fate in rodents. Mol Imaging 7: 77-91.
8. Wessels JT, Busse AC, Mahrt J, Dullin C, Grabbe E, et al. (2007) In vivo imaging in experimental preclinical tumor research-a review. Cytometry A 71: 542-549.
9. Nahrendorf M, Waterman P, Thurber G, Groves K, Rajopadhye M, et al. (2009) Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol 29: 1444-1451.
10. Mulder WJ, Castermans K, van Beijnum JR, Oude Egbrink MG, Chin PT, et al. (2009) Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots. Angiogenesis 12: 17-24.
11. Lecchi M, Ottobrini L, Martelli C, Del Sole A, Lucignani G, (2007) Instrumentation and probes for molecular and cellular imaging. Q J Nucl Med Mol Imaging 51: 111-126.
12. Hsu AR, Cai W, Veeravagu A, Mohamedali KA, Chen K, et al. (2007) Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. J Nucl Med 48: 445-454.
13. Bhushan KR, Misra P, Liu F, Mathur S, Lenkinski RE, et al. (2008) Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe. J Am Chem Soc 130: 17648-17649.
14. Cai W, Niu G, Chen X, (2008) Multimodality imaging of the HER-kinase axis in cancer. Eur J Nucl Med Mol Imaging 35: 186-208.
15. Vanderheyden JL, (2009) The use of imaging in preclinical drug development. Q J Nucl Med Mol Imaging 53: 374-381.
16. Stell A, Belcredito S, Ramachandran B, Biserni A, Rando G, et al. (2007) Multimodality imaging: novel pharmacological applications of reporter systems. Q J Nucl Med Mol Imaging 51: 127-138.
17. Medina-Kauwe LK, Kasahara N, Kedes L, (2001) 3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins. Gene Ther 8: 795-803.
18. Medina-Kauwe LK, Maguire M, Kasahara N, Kedes L, (2001) Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins. Gene Ther 8: 1753-1761.
19. Agadjanian H, Ma J, Rentsendorj A, Valluripalli V, Hwang JY, et al. (2009) Tumor detection and elimination by a targeted gallium corrole. Proc Natl Acad Sci U S A 106: 6105-6110.
20. Gregory CW, Whang YE, McCall W, Fei X, Liu Y, et al. (2005) Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth. Clin Cancer Res 11: 1704-1712.
21. Jeschke M, Wels W, Dengler W, Imber R, Stöcklin E, et al. (1995) Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins. Int J Cancer 60: 730-739.
22. Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, et al. (1996) Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Res 56: 1457-1465.
23. van der Horst EH, Weber I, Ullrich A, (2005) Tyrosine phosphorylation of PYK2 mediates heregulin-induced glioma invasion: novel heregulin/HER3-stimulated signaling pathway in glioma. Int J Cancer 113: 689-698.
24. Hwang JY, Wachsmann-Hogiu S, Ramanujan VK, Ljubimova J, Gross Z, et al. (2011) A Multimode Optical Imaging System for Preclinical Applications In Vivo: Technology Development, Multiscale Imaging, and Chemotherapy Assessment. Mol Imaging Biol (Epub ahead of print).
25. Hwang JY, Gross Z, Gray HB, Medina-Kauwe LK, Farkas DL, (2011) Ratiometric spectral imaging for fast tumor detection and chemotherapy monitoring in vivo. J Biomed Opt 16: 066007.
26. Agadjanian H, Chu D, Hwang JY, Wachsmann-Hogiu S, Rentsendorj A, et al. (2012) Chemotherapy Targeting by DNA Capture in Viral Protein Particles. Nanomedicine 7: 335-352.
27. Sun L, Richard WD, Cannata JM, Feng CC, Johnson JA, et al. (2007) A high-frame rate high-frequency ultrasonic system for cardiac imaging in mice. IEEE Trans Ultrason Ferroelectr Freq Control 54: 1648-1655.
28. Wei HJ, Xing D, Wu GY, Jin Y, Gu HM, (2004) Optical properties of human normal small intestine tissue with theoretical model of optics about biological tissues at Ar+ laser and 532 nm laser and their linearly polarized laser irradiation in vitro. Guang Pu Xue Yu Guang Pu Fen Xi 24: 524-528.
29. Brand S, Solanki B, Foster DB, Czarnota GJ, Kolios MC, (2009) Monitoring of cell death in epithelial cells using high frequency ultrasound spectroscopy. Ultrasound Med Biol 35: 482-493.
30. Czarnota GJ, Kolios MC, Abraham J, Portnoy M, Ottensmeyer FP, et al. (1999) Ultrasound imaging of apoptosis: high-resolution non-invasive monitoring of programmed cell death in vitro, in situ and in vivo. Br J Cancer 81: 520-527.
31. Vlad RM, Kolios MC, Moseley JL, Czarnota GJ, Brock KK, (2010) Evaluating the extent of cell death in 3D high frequency ultrasound by registration with whole-mount tumor histopathology. Med Phys 37: 4288-4297.
32. Vlad RM, Kolios MC, Czarnota GJ, (2011) Ultrasound imaging of apoptosis: spectroscopic detection of DNA-damage effects at high and low frequencies. Methods Mol Biol 682: 165-187.
33. Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A, (2003) Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 63: 1936-1942.
34. Hennings L, Kaufmann Y, Griffin R, Siegel E, Novak P, et al. (2009) Dead or alive? Autofluorescence distinguishes heat-fixed from viable cells. Int J Hyperthermia 25: 355-363.